RESUMO
The objective of this study was to perform a quality control assessment of red blood cells after standardization of the blood production stages. For this purpose, separation of the blood components to obtain red blood cells, the storage of the blood packets and an evaluation of blood quality were performed. The mean (± SD) volume, globular volume, hemoglobin and hemolysis percentage of the red blood cell concentrate were 299.77±30.08mL, 60.87±2.60%, 20.57±0.93g/DL and 0.09±0.07%, respectively. The means (± SD) of the volume, globular volume, total hemoglobin percentage of hemolysis and hemoglobin per unit of packed red blood cells after the storage period (8.83±6.73 days) were 57.55±3.01%, 20.30±0.89 0, 20±0.12%, and 60.90±7.65. The red blood cell packets were within the parameters of quality control established by Health Ministry legislation in humans and allow us to conclude that the standardization of blood production stages involves the selection of donors until the end of storage and is necessary to produce quality red blood cells. Quality control aims to find possible flaws in the procedures to be repaired, increasing transfusion safety.(AU)
O objetivo deste estudo foi realizar o controle de qualidade do concentrado de hemácias após a padronização das etapas de produção do sangue. Para isso, realizou-se separação de hemocomponentes para obtenção de concentrado de hemácias, armazenamento das bolsas de sangue e avaliação da qualidade delas. Os valores médios (± DP) do volume, do volume globular, da hemoglobina e do percentual de hemólise do concentrado de hemácias foram: 299,77±30,08mL, 60,87±2,60%, 20,57±0,93g/DL e 0,09±0,07%, respectivamente. Os valores médios (± DP) do volume globular, da hemoglobina total percentual de hemólise e da hemoglobina por unidade de concentrado de hemácias após o período de armazenamento (8,83±6,73 dias) foram: 57,55±3,01%, 20,30±0,89 0,20±0,12%, 60,90±7,65. As bolsas de concentrado de hemácias ficaram dentro dos parâmetros de controle de qualidade estabelecidos pela legislação do Ministério da Saúde em humanos e possibilitaram concluir que a padronização das etapas de produção do sangue envolve desde a seleção de doadores até o final do armazenamento e é necessária para produzir concentrado de hemácias com qualidade. O controle de qualidade visa encontrar possíveis falhas nos procedimentos para que estas possam ser reparadas, aumentando, assim, a segurança transfusional.(AU)
Assuntos
Animais , Cães , Cães/sangue , Eritrócitos/classificação , Medicina Transfusional/classificaçãoRESUMO
BACKGROUND AND AIMS: Low vitamin D (vitD) has been linked to increased cardiovascular (CV) risk, but the effects of vitD supplementation are not clarified. We evaluated the impact of vitD normalization on HDL cholesterol efflux capacity (CEC), which inversely correlates with CV risk, the proatherogenic serum cholesterol loading capacity (CLC), adipokine profile and subclinical atherosclerosis. METHODS AND RESULTS: Healthy premenopausal women with vitD deficiency (n = 31) underwent supplementation. Subclinical atherosclerosis was evaluated by flow-mediated dilation (FMD), pulse wave velocity (PWV) and augmentation index (AIx), measured with standard techniques. HDL CEC and serum CLC were measured by a radioisotopic and fluorimetric assay, respectively. Malondialdehyde (MDA) in HDL was quantified by the TBARS assay. Pre-ß HDL was assessed by 2D-electrophoresis. Serum adipokines were measured by ELISA. VitD replacement restored normal levels of serum 25-hydroxyvitamin D (25OHD) and significantly improved FMD (+4%; p < 0.001), PWV (-4.1%: p < 0.001) and AIx (-16.1%; p < 0.001). Total CEC was significantly improved (+19.5%; p = 0.003), with a specific increase in the ABCA1-mediated CEC (+70.8%; p < 0.001). HDL-MDA slightly but significantly decreased (-9.6%; p = 0.027), while no difference was detected in pre-ß HDL. No change was observed in aqueous diffusion nor in the ABCG1-mediated CEC. Serum CLC was significantly reduced (-13.3%; p = 0.026). Levels of adiponectin were increased (+50.6%; p < 0.0001) and resistin levels were decreased (-24.3%; p < 0.0001). After vitD replacement, an inverse relationship was found linking the ABCA1-mediated CEC with pre-ß HDL (r2 = 0.346; p < 0.001) and resistin (r2 = 0.220; p = 0.009). CONCLUSION: Our data support vitD supplementation for CV risk prevention.
Assuntos
Adipocinas/sangue , Aterosclerose/prevenção & controle , Colecalciferol/administração & dosagem , HDL-Colesterol/sangue , Suplementos Nutricionais , Lipoproteínas de Alta Densidade Pré-beta/sangue , Pré-Menopausa/sangue , Deficiência de Vitamina D/tratamento farmacológico , Transportador 1 de Cassete de Ligação de ATP/metabolismo , Adulto , Doenças Assintomáticas , Aterosclerose/sangue , Aterosclerose/diagnóstico , Aterosclerose/etiologia , Biomarcadores/sangue , Colecalciferol/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Feminino , Humanos , Estudo de Prova de Conceito , Resistina/sangue , Fatores de Tempo , Resultado do Tratamento , Turquia , Vitamina D/análogos & derivados , Vitamina D/sangue , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/diagnósticoRESUMO
OBJECTIVES: It has been suggested that a low plasma high-density lipoprotein cholesterol (HDL-C) level contributes to the high cardiovascular disease risk of patients with chronic kidney disease (CKD), especially those undergoing haemodialysis (HD). The present study was conducted to gain further understanding of the mechanism(s) responsible for the low HDL-C levels in patients with CKD and to separate the impact of HD from that of the underlying CKD. METHODS: Plasma lipids and lipoproteins, HDL subclasses and various cholesterol esterification parameters were measured in a total of 248 patients with CKD, 198 of whom were undergoing HD treatment and 40 healthy subjects. RESULTS: Chronic kidney disease was found to be associated with highly significant reductions in plasma HDL-C, unesterified cholesterol, apolipoprotein (apo)A-I, apoA-II and LpA-I:A-II levels in both CKD cohorts (with and without HD treatment). The cholesterol esterification process was markedly impaired, as indicated by reductions in plasma lecithin:cholesterol acyltransferase (LCAT) concentration and activity and cholesterol esterification rate, and by an increase in the plasma preß-HDL content. HD treatment was associated with a further lowering of HDL levels and impaired plasma cholesterol esterification. The plasma HDL-C level was highly significantly correlated with LCAT concentration (R = 0.438, P < 0.001), LCAT activity (R = 0.243, P < 0.001) and cholesterol esterification rate (R = 0.149, P = 0.031). Highly significant correlations were also found between plasma LCAT concentration and levels of apoA-I (R = 0.432, P < 0.001), apoA-II (R = 0.275, P < 0.001), LpA-I (R = 0.326, P < 0.001) and LpA-I:A-II (R = 0.346, P < 0.001). CONCLUSION: Acquired LCAT deficiency is a major cause of low plasma HDL levels in patients with CKD, thus LCAT is an attractive target for therapeutic intervention to reverse dyslipidaemia, and possibly lower the cardiovascular disease risk in these patients.
Assuntos
Hipoalfalipoproteinemias/etiologia , Deficiência da Lecitina Colesterol Aciltransferase/complicações , Insuficiência Renal Crônica/complicações , Apolipoproteínas/metabolismo , Estudos de Casos e Controles , HDL-Colesterol/metabolismo , Esterificação/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fosfatidilcolina-Esterol O-Aciltransferase/metabolismo , Diálise Renal/efeitos adversos , Insuficiência Renal Crônica/sangue , Triglicerídeos/metabolismoRESUMO
Foram utilizados 28.050 registros de bovinos Nelore para estabelecer critérios de seleção para bovinos de corte, considerando as características ganho médio diário do nascimento à desmama (GND), dias para o animal ganhar 160kg do nascimento à desmama (D160), ganho médio diário da desmama ao sobreano (D240) e dias para o animal ganhar 240kg da desmama ao sobreano (D240). As estimativas de herdabilidade foram: GND, 0,20; D160, 0,19; GDS, 0,07; e D240, 0,03. Considerando os efeitos maternos, a herdabilidade da característica D160 foi 0,16 e a da GND, 0,06. Verificou-se correlação genética alta e negativa entre GND e D160 (-0,95) e negativas entre efeito genético direto do GND e efeito genético materno da mesma característica (-0,24) e entre efeitos genéticos diretos do GND e do D160 (-0,15). Houve associação positiva entre o efeito genético materno de GND e direto de GDS (0,33), e correlação nula entre o efeito genético direto das características D160 e D240. Conclui-se que a velocidade de crescimento pode ser modificada adotando-se como critério de seleção qualquer uma das duas características do período pré-desmama, apesar deles não selecionarem os mesmos animais, principalmente se na adoção do critério forem considerados os efeitos maternos no período pré-desmama e os efeitos genéticos diretos no período pós-desmama. As magnitudes das correlações estimadas entre as características nos períodos pré e pós-desmama foram baixas, indicando que os animais poderiam ser selecionados no período pré-desmama, independente do critério de seleção adotado na pós-desmama.
Assuntos
Animais , Masculino , Feminino , Bovinos , Melhoramento Genético , Aumento de PesoRESUMO
The results from more than 8,000 stool cultures performed on the Hospital personnel during the last 4 years are reported. A total of 70 were positive and the strains more frequently isolated were S. wien, S. london and S. typhimurium. Epidemiological implications, control measures and care of exposed persons are presented and discussed.
Assuntos
Portador Sadio/epidemiologia , Infecção Hospitalar/epidemiologia , Infecções por Salmonella/epidemiologia , Infecção Hospitalar/prevenção & controle , Humanos , Itália , Recursos Humanos em Hospital , Infecções por Salmonella/prevenção & controleRESUMO
835 isolates for Samonellae have been obtained from more than 32,000 stool cultures carried out on healthy persons living in the Frosinone district during 1974-1978. The strains typed were 786 and any of more than 37 serotypes have been identified. S. wien showed the highest incidence.